An on-demand video of “Customs and FDA Enforcement: Challenges for Imports In 2025” is available free for SeafoodSource Premium members and for USD 350 (EUR 308) to non-members through the Complete ...

The US Food and Drug Administration (FDA) has approved Takeda’s new immunoglobulin (IG) therapy, Gammagard liquid ERC [immune ...

The strategies that the industry’s lobbyists use, or don’t deploy, matter as the Trump administration moves more decisively against the industry than during his first term— pulling vaccine ...

Boston: TOBY, Inc., a biotech startup advancing non-invasive cancer detection through urine-based volatilomics and Artificial ...

Hemispherian AS, a pioneering biotech company developing next-generation therapeutics for aggressive cancers, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug ...

The Bureau of Customs (BOC), along with the Department of Health (DOH) and the Department of Agriculture (DA), unveiled ...

The Department of Justice’s 2025 national health care fraud investigation resulted in hundreds of defendants nationwide being ...

FDA 510(k) application submitted to allow marketing of the ARC-EX® System for home use in the United StatesCE Mark ...

The FDA has accepted Aquestive Therapeutics’ new drug application for its Anaphylm sublingual epinephrine film for treating ...

Public health officials continue to identify patients in a Salmonella Montevideo outbreak traced to fresh cucumbers, even ...

Optiscan Imaging is recruiting patients into a Melbourne trial of its innovative precision surgery and pathology devices to improve breast cancer surgeries.

Mesoblast shares lifted in morning trade after the biotech said it had aligned with the US Food and Drug Administration (FDA) ...